The event is a one-on-one analyst/institutional investor meeting.
The meeting is scheduled for 20th November, 2026 at 1600 hrs IST.
The meeting will be held in person at the Corporate Office, BKC, Mumbai.
The stated counterparty for the meeting is Alpha Alternatives.
The company explicitly states that no Unpublished Price Sensitive Information (UPSI) will be shared at this meeting.
The disclosure is made pursuant to Regulation 30 read with Schedule III Part A Para A of the SEBI (LODR) Regulations, 2015 and relevant SEBI circulars.
The document includes a note that the date of the meeting is subject to change.
Additional Notes Section
The disclosure is signed by Arvind Patkar, Company Secretary and Compliance Officer (Membership No.: ACS 21577).
The document reference number is UTI/AMC/CS/SE/2026-27/0738 and it is dated 16th November, 2026.
No financial data, performance figures, guidance, or strategic updates were disclosed in this announcement. The document is purely a scheduling intimation.
No information was provided regarding management participants from UTI AMC, presentation materials, or availability of transcripts/recordings.